PMC:7441788 / 19711-20217
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T185 | 34-39 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
| T186 | 262-267 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T187 | 271-274 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 3–5 |
| T188 | 296-301 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T240 | 34-39 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
| T241 | 68-73 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T242 | 87-99 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
| T243 | 100-105 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T244 | 122-127 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T245 | 206-218 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
| T246 | 433-437 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T137 | 87-99 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
| T138 | 206-218 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T148 | 10-280 | Sentence | denotes | Gautret et al.[57] Open label, nonrandom cohort study HCQ group: n = 12; HCQ＋azithromycin group: n = 6; control group: n = 12 HCQ (200 mg/3 times/day for 10 days) HCQ alone or in combination with azithromycin could effectively eliminate nasopharyngeal virus in 3–5 days. |
| T149 | 281-342 | Sentence | denotes | Nasopharyngeal virus determination was used as main endpoint. |
| T150 | 343-492 | Sentence | denotes | Small sample size; Six patients dropped out due to critical illness or intolerance to the drug; Lack of clinical outcomes; Limited follow-up results. |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 686 | 64-67 | Chemical | denotes | HCQ | MESH:D006886 |
| 687 | 83-86 | Chemical | denotes | HCQ | MESH:D006886 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T122 | 262-267 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T123 | 296-301 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 686 | 64-67 | Chemical | denotes | HCQ | MESH:D006886 |
| 687 | 83-86 | Chemical | denotes | HCQ | MESH:D006886 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T148 | 10-280 | Sentence | denotes | Gautret et al.[57] Open label, nonrandom cohort study HCQ group: n = 12; HCQ＋azithromycin group: n = 6; control group: n = 12 HCQ (200 mg/3 times/day for 10 days) HCQ alone or in combination with azithromycin could effectively eliminate nasopharyngeal virus in 3–5 days. |
| T149 | 281-342 | Sentence | denotes | Nasopharyngeal virus determination was used as main endpoint. |
| T150 | 343-492 | Sentence | denotes | Small sample size; Six patients dropped out due to critical illness or intolerance to the drug; Lack of clinical outcomes; Limited follow-up results. |